Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration

BACKGROUND: The introduction of anti-vascular endothelial growth factor (anti-VEGF) drugs to ophthalmology has revolutionized the treatment of neovascular age-related macular degeneration (nAMD). Despite this significant progress, gaps and challenges persist in the diagnosis of nAMD, initiation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wykoff, Charles C., Clark, W. Lloyd, Nielsen, Jared S., Brill, Joel V., Greene, Laurence S., Heggen, Cherilyn L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408401/
https://www.ncbi.nlm.nih.gov/pubmed/29383980
http://dx.doi.org/10.18553/jmcp.2018.24.2-a.s3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408401/
https://www.ncbi.nlm.nih.gov/pubmed/29383980
http://dx.doi.org/10.18553/jmcp.2018.24.2-a.s3

Ejemplares similares